BostonGene’s mission is to power healthcare’s transition to personalized medicine using AI-based molecular and immune profiling to improve the standard of care, accelerate research, and improve economics. The BostonGene Tumor Portrait Test, a comprehensive integrated genomic and transcriptomic analysis of tumors and the microenvironment, reveals key drivers of each tumor. This company was founded in 2015 by Andrew Feinberg and is headquartered in Boston, MA.

Register for Details

For more details on financing and valuation for BostonGene, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about BostonGene

Forge green plus iconForge green minus icon

What is BostonGene's IPO price?

The IPO price for BostonGene will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in BostonGene?

BostonGene is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell BostonGene shares pre-IPO?

If you own BostonGene pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is BostonGene a publicly traded company?

BostonGene is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is BostonGene's funding to date?

BostonGene has raised $200MM to date.
Forge green plus iconForge green minus icon

When was BostonGene founded?

BostonGene was founded in 2015.

BostonGene Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
4/6/2022 Series B $150MM raised $XXX.XX $XXX.XX
4/24/2019 Series A $50MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: May 21, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.